Regular blood testing to check for toxicity from standard rheumatoid arthritis drugs is recommended. However, guidelines are vague as to how frequently and for how long such testing should occur.
Most events of acute neurotoxicity were reported to occur during consolidation or interim maintenance I. Researchers developed a new risk prediction model for methotrexate-related neurotoxicity in ...
ABSTRACT: Neuroleptic Malignant Syndrome (NMS) and anticholinergic toxicity are two different but clinically similar disorders that are commonly seen in neuropsychiatric and emergency toxicological ...
Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Refractory Melanoma (ILLUMINATE-301) R1 compared induction ...
Glucarpidase may improve kidney function and other sequelae in patients with methotrexate-induced acute kidney injury. High-dose methotrexate frequently causes acute kidney injury (MTX-AKI), ...
Please provide your email address to receive an email when new articles are posted on . Patients who received glucarpidase for acute kidney injury from methotrexate treatment had improved kidney ...
THURSDAY, Jan. 16, 2025 (HealthDay News) — For patients with methotrexate (MTX)-acute kidney injury (AKI), glucarpidase is associated with improved renal and extrarenal outcomes, according to a study ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback